Edward Kliphuis has departed from his position as a Spain-based investment director at M Ventures, the investment arm of Germany-headquartered pharmaceutical company Merck Group.
Venture capital firm Amadeus Capital Partners has hired Kliphuis as a partner, and he will help lead its scale investment activities under the firm’s managing partner, Andrea Traversone.
Kliphuis said: “Amadeus has a long history of forward thinking with investments such as Vocal IQ, Solexa and Graphcore. The scale team will be applying this knowledge and experience to backing entrepreneurial businesses in healthtech, industrial technology and agritech across Europe.”
Investments led by Kliphuis during his time at M Ventures included Akili Interactive Labs, the developer of the first prescription video game to get approval from the Food and Drug Administration, as well as battery-free Bluetooth tag provider Wiliot and voice analysis technology developer Sonde Health.
Prior to M Ventures, Kliphuis was a life sciences market analyst at investment bank Kempen, covering listed small and mid-cap life sciences equities, having originally begun his career as an analyst in M Ventures’ biopharma investment team in 2009.
The move comes as Amadeus has hired Kai Schmitz, formerly from International Finance Corporation, for a Colombia-based position where he will invest in Latin America alongside existing partner Pat Burtis, in addition to Ana Bernardo-Gancedo, formerly at OC&C Strategy Consultants, as a healthcare analyst.
Photo courtesy of LinkedIn.
